evaluated the expression levels of NPC1L1 and NPC2 in HCC using immunohistochemistry, Western blot, and real‐time PCR and found that the expression of NPC1L1 and NPC2 was significantly lower in cancerous tissue compared to adjacent non‐cancerous tissue. The gene discussed is NPC2; the disease is hepatocellular carcinoma.